•  
  •  
 

Abstract

Introduction. Right ventricular dysfunction is one of the common complication of chronic obstructive pulmonary disease (COPD). Right ventricular assessment is importance, since it related with exercise intolerance and poor prognosis. Methods. Thirty stable COPD men (mean age: 65 ± 6 yr) underwent spirometry. In addition to conventional echocardiographic parameters, TAPSE, right heart chambers, and trans tricuspid inflow were determined. Results. The mean value of FEV1 was 28 ± 8% of the predicted value. There was no subject with mild airflow limitation, 57% subjects were with very severe airflow obstruction. All of pulmonary function test showed mixed restrictive-obstructive pattern. Mean of right chamber was in normal limit. Forty percent of the patients suffered right ventricular diastolic dysfunction. Means of TAPSE was 16.96 ± 96 mm. Sixty percent of the patients suffered right ventricular systolic dysfunction. There was no significant difference in TAPSE between groups with moderate-severe flow obstruction and very severe airflow obstruction. There was no significant correlation between FEV1 % prediction and TAPSE, so the cut-off value between the two variables cannot be determined. Conclusions. The proportion of right ventricular systolic dysfunction was 60% and diastolic dysfunction was 40%. There was no correlation between FEV1 % prediction and TAPSE. The cut-off value between the two variable in stable COPD patients cannot be determined.

References

1. Vestbo J, Hurd SS, Agustí AG, Jones PW, Vogelmeier C, Anzueto A, Barnes PJ, Fabbri LM, Martinez FJ, Nishimura M, Stockley RA, Sin DD, Rodriguez-Roisin R. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary.Am J Respir Crit Care Med. 2013;187(4):347-65. 2. Departemen Kesehatan Republik Indonesia, Direktorat Jenderal Pengendalian Penyakit dan penyehatan Lingkungan Direktorat pengendalian Penyakit Tidak Menular. Pedoman Pengendalian Penyakit Paru obstruktif kronik (PPOK). Jakarta: Depkes RI; 2008. 3. Kemenkes RI Dirjen P2PL. Pedoman Pengendalian PPOK. Jakarta: Kemenkes RI; 2008. hal.6-7 4. Perhimpunan Dokter Paru Indonesia. Penyakit paru obstruktif kronik (PPOK). Jakarta: PDPI; 2003. 5. Murray CJ. Lopez AD. Global mortality, disability, and contribution of risk factors: global burden of disease study. Lancet. 1997;349(9063):1436-42. 6. Celli B R, Pauwels R,Snider G L. American Thorasic Society and European Respiratory society. Standard for diagnosis and management of patients with COPD. Eur Respir J. 2004;23(6):932-46. 7. Weitzenblum E. Chronic cor pulmonal. Heart. 2003;89(2):225-30. 8. Macnee W. Pathophysiology of cor pulmonale in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1994;150(3):833-52. 9. Burgess MI, Mogulkoc N, Bright-Thomas RJ. Comparison of echocardiographic markers of right ventricular function in determining prognosis in chronic pulmonary disease. J Am Soc Echocardiogr. 2002;15(6):633-9. 10. Afonso ASM, Verhamme KMC, Stukenboom MCJM, Brusselle GGO. COPD in the general population: Prevalence, incidence and survival. Respir Med. 2011;105(12):1872-84. 11. Raherison C, Girodet PO. Epidemiology of COPD. Eur Respir Rev. 2009;18(114):1872-84. 12. Thompson WH, St-Hilaire S. Prevalence of chronic obstructive pulmonary disease and tobacco use in veterans at Boise Veterans Affairs Medical Center.Respir Care. 2010;55(5):555-60. 13. Foreman MG, Zhang L, Murphy J. Early-onset chronic obstructive pulmonary disease is associated with female sex, maternal factors, and African American race in the COPD Gene Study. Am J Respir Crit Med. 2011;184(4):414-20. 14. Silverman EK, Weiss ST, Drazen JM. Gender-related differences in severe, early-onset chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2000;162(6):2152-8. 15. Halbert RJ, Natoli JL, Badamgarav E, Buist AS, Mannino DM. Global burden of COPD: systemic review and meta-analysis. Eur Respir J. 2006;28(3):523-32. 16. Schols AM, Slagen J, Volovics L. Weight loss is a reversible factor in the prognosis of chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1998;157(6 pt 1):1791-7. 17. Raguso CA. Luthy C. Nutritional status in chronic obstructive pulmonary disease: role of hypoxia. Nutrition. 2011;27(2):138-43. 18. King DA, Cordova F, Scharf SM. Nutritional aspects of chronic obstructive pulmonary disease. Proc Am Thorac Soc. 2008;5(4):519-23. 19. Falk JA, Kadiev S, Criner GJ, Scharf Sm, Minais OA, Diaz P. Cardiac disease in chronic obstructive pulmonary disease.Proc Am Throrac Soc. 2008,5(4):543-8. 20. Sin DD, Anthnisen NR, Soriano JB, Agusti AG. Mortality in COPD: role of comorbidities. Eur Respir J. 2006;28(6):1245-57. 21. Ferlinz J. Right ventricular performance in essential hypertension. Br Heart J. 1981;46(1):156-62. 22. Klinger JR, Hill NS. Right ventricular dysfunction in chronic obstructive pulmonary disease: Evaluation and management. Chest. 1991;99(3):715-23. 23. Hansel TT, Barnes PJ. New drugs for exacerbations of chronic obstructive pulmonary disease. Lancet. 2009;374(9691):744-55. 24. Al-Ashkar F, Mehra R, Mazzone PJ. Interpreting pulmonary function tests: recognize the pattern, and the diagnosis will follow. Cleve Clin J Med. 2003;70(10):866-81. 25. Sewa DW, Ong TH. Pulmonary function test: spirometry. Proc SingHealth. 2014;23(1):57-64. 26. Ozben B, Eryuksel E, Tanrikulul AM, Papilal N, Ozyigit T, Celikel T, dkk. Acute exacerbation impairs right ventricular function in COPD patients. Hellenic J Cardiol. 2015;56(4): 324-3. 27. Terzano C, Romani S, Gaudio C, Pelliccia F, Serao M, Vitaelli A. Right heart functional changes in the acute, hypercapnic exacerbations of COPD. BiomedRes Int.2014;14:51-7. 28. Mannino DM, Watt G, Hole D, Gillis C, Hart C, McConnachie A, et al. The natural history of chronic obstructive pulmonary disease. Eur Respir J. 2006;27(3):627-43. 29. Akcay M, Yeter E, Durmayi T, Keles T, Bayram NA, Uyar M, dkk. Treatment of acute chronic obstructive pulmonary disease exacerbation improves right ventricle function. Eur J Echocardiogr. 2010;11(6):530-6. 30. Kjaergaard J, Akkan D, Iversen KK, Kober L, Torp-Pedersen C, Hassager C. Right ventricular dysfunction as an independent predictor of short-and long-term mortality in patients with heart failure. Eur J Heart Fail. 2007;9(6):610-16. 31. Schoos M, Dalsgaard M, Kjaergaard J, Moesby D, Jensen SG, Steffensen I, et al. Echocardiographic predictors of excercise cpacity and mortality in chronic obstructive pulmonary disease. BMC Cardiovasc Disord. 2013;13:84-91. 32. Grossman W. Evaluation of systolic and diastolic function of the myocardium. In: Baim DD, Grossman W, editors. Cardiac catheterization, angiography, and intervention. Baltimore:Williams and Wilkins, 1996. p.333-59.

Download

Share

COinS
 
 

To view the content in your browser, please download Adobe Reader or, alternately,
you may Download the file to your hard drive.

NOTE: The latest versions of Adobe Reader do not support viewing PDF files within Firefox on Mac OS and if you are using a modern (Intel) Mac, there is no official plugin for viewing PDF files within the browser window.